In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.
about
Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphismShort-sequence DNA repeats in prokaryotic genomesRapid identification of Candida species with species-specific DNA probesComparative genomics of wild type yeast strains unveils important genome diversityEpidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic methodTrends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolatesReverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples.Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains.The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen.Whole Genome Analysis of 132 Clinical Saccharomyces cerevisiae Strains Reveals Extensive Ploidy VariationSignificance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation.Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits.Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccharomyces isolates.Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.
P2860
Q24522336-CF501688-E78D-4650-B47F-052EB68C9121Q24548611-28D9FDD1-E70C-4580-96F7-DD52A74CA228Q31998547-F8D11BB3-49ED-494A-AB56-23FD4CDC1FF9Q33382530-4A022E1C-1A5B-4763-875E-3F3187F870A0Q33657453-4B3A0A5A-F0B1-48C4-9581-68125194BF6CQ33959121-60E8AE7A-3F6D-4E5E-A14C-C268D2160E43Q33961452-ED383230-6C01-45AB-9BE2-B4CE2B70F96DQ33966544-7BE538DF-53AE-48FB-8D20-C1391B8D6094Q33971185-F16D2085-78A3-4C39-A684-052FA8D3B860Q35561978-31B45966-49B3-4852-9BBA-ABA49A55638DQ37163002-7D515609-3FAA-48CA-87E8-724C323E4C5DQ37419898-BE6B314C-6561-422A-8F1B-23543E9EB319Q39235548-598E88CF-148D-4AF6-A92B-A4C9E5EAB3CBQ40013948-F480F254-DB21-4768-813D-657EE4DBFFABQ46300594-A5CDC959-7453-4825-ACF7-5EFB884729DB
P2860
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@ast
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@en
type
label
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@ast
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@en
prefLabel
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@ast
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@en
P2093
P2860
P1476
In vitro susceptibility testin ...... cerevisiae clinical isolates.
@en
P2093
P2860
P304
P407
P577
1996-12-01T00:00:00Z